S&P 500   5,135.38 (-0.03%)
DOW   38,996.76 (-0.23%)
QQQ   444.70 (-0.20%)
AAPL   174.16 (-3.06%)
MSFT   415.56 (+0.01%)
META   501.03 (-0.25%)
GOOGL   132.60 (-3.31%)
AMZN   178.11 (-0.06%)
TSLA   186.92 (-7.76%)
NVDA   865.30 (+5.17%)
NIO   5.32 (-7.96%)
AMD   206.85 (+2.08%)
BABA   71.82 (-3.75%)
T   16.80 (-1.06%)
F   12.86 (+3.29%)
MU   96.69 (+1.62%)
CGC   3.00 (-6.54%)
GE   160.58 (+1.22%)
DIS   113.78 (+1.63%)
AMC   4.31 (-1.15%)
PFE   25.77 (-3.08%)
PYPL   59.61 (-1.54%)
XOM   104.47 (-1.29%)
S&P 500   5,135.38 (-0.03%)
DOW   38,996.76 (-0.23%)
QQQ   444.70 (-0.20%)
AAPL   174.16 (-3.06%)
MSFT   415.56 (+0.01%)
META   501.03 (-0.25%)
GOOGL   132.60 (-3.31%)
AMZN   178.11 (-0.06%)
TSLA   186.92 (-7.76%)
NVDA   865.30 (+5.17%)
NIO   5.32 (-7.96%)
AMD   206.85 (+2.08%)
BABA   71.82 (-3.75%)
T   16.80 (-1.06%)
F   12.86 (+3.29%)
MU   96.69 (+1.62%)
CGC   3.00 (-6.54%)
GE   160.58 (+1.22%)
DIS   113.78 (+1.63%)
AMC   4.31 (-1.15%)
PFE   25.77 (-3.08%)
PYPL   59.61 (-1.54%)
XOM   104.47 (-1.29%)
S&P 500   5,135.38 (-0.03%)
DOW   38,996.76 (-0.23%)
QQQ   444.70 (-0.20%)
AAPL   174.16 (-3.06%)
MSFT   415.56 (+0.01%)
META   501.03 (-0.25%)
GOOGL   132.60 (-3.31%)
AMZN   178.11 (-0.06%)
TSLA   186.92 (-7.76%)
NVDA   865.30 (+5.17%)
NIO   5.32 (-7.96%)
AMD   206.85 (+2.08%)
BABA   71.82 (-3.75%)
T   16.80 (-1.06%)
F   12.86 (+3.29%)
MU   96.69 (+1.62%)
CGC   3.00 (-6.54%)
GE   160.58 (+1.22%)
DIS   113.78 (+1.63%)
AMC   4.31 (-1.15%)
PFE   25.77 (-3.08%)
PYPL   59.61 (-1.54%)
XOM   104.47 (-1.29%)
S&P 500   5,135.38 (-0.03%)
DOW   38,996.76 (-0.23%)
QQQ   444.70 (-0.20%)
AAPL   174.16 (-3.06%)
MSFT   415.56 (+0.01%)
META   501.03 (-0.25%)
GOOGL   132.60 (-3.31%)
AMZN   178.11 (-0.06%)
TSLA   186.92 (-7.76%)
NVDA   865.30 (+5.17%)
NIO   5.32 (-7.96%)
AMD   206.85 (+2.08%)
BABA   71.82 (-3.75%)
T   16.80 (-1.06%)
F   12.86 (+3.29%)
MU   96.69 (+1.62%)
CGC   3.00 (-6.54%)
GE   160.58 (+1.22%)
DIS   113.78 (+1.63%)
AMC   4.31 (-1.15%)
PFE   25.77 (-3.08%)
PYPL   59.61 (-1.54%)
XOM   104.47 (-1.29%)

Welltower (WELL) Stock Price, News & Analysis

$93.17
+0.45 (+0.49%)
(As of 01:39 PM ET)
Today's Range
$91.05
$93.27
50-Day Range
$86.51
$94.25
52-Week Range
$65.18
$94.63
Volume
839,299 shs
Average Volume
2.62 million shs
Market Capitalization
$53.00 billion
P/E Ratio
145.58
Dividend Yield
2.62%
Price Target
$92.79

Welltower MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.79 Rating Score
Upside/​Downside
0.1% Upside
$92.79 Price Target
Short Interest
Healthy
0.97% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.13
Upright™ Environmental Score
News Sentiment
0.97mentions of Welltower in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.22%
From $4.01 to $4.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.80 out of 5 stars

Finance Sector

382nd out of 864 stocks

Real Estate Investment Trusts Industry

77th out of 179 stocks


WELL stock logo

About Welltower Stock (NYSE:WELL)

Welltower Inc. (NYSE:WELL), a REIT and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

WELL Stock Price History

WELL Stock News Headlines

Wells Fargo Sticks to Its Buy Rating for Welltower (WELL)
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Welltower Inc's Dividend Analysis
Welltower Inc.: Welltower Reports Fourth Quarter 2023 Results
Decoding Welltower Inc (WELL): A Strategic SWOT Insight
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Q4 2023 Welltower Inc Earnings Call
Buy Rating for Welltower: Strong Q4 FFO and Positive Growth Prospects
Welltower: Q4 Earnings Snapshot
Welltower Swings To Profit In Q4
Welltower Reports Fourth Quarter 2023 Results
Welltower Inc Reports Robust Growth in Q4 2023 Earnings
Welltower (WELL) Beats Q4 FFO and Revenue Estimates
See More Headlines
Receive WELL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Welltower and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Ex-Dividend for 3/7 Dividend
2/22/2024
Today
3/04/2024
Dividend Payable
3/07/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
CUSIP
42217K10
Employees
533
Year Founded
1970

Price Target and Rating

Average Stock Price Target
$92.79
High Stock Price Target
$115.00
Low Stock Price Target
$80.00
Potential Upside/Downside
-0.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Net Income
$340.09 million
Pretax Margin
5.27%

Debt

Sales & Book Value

Annual Sales
$6.64 billion
Cash Flow
$3.24 per share
Book Value
$47.12 per share

Miscellaneous

Free Float
568,423,000
Market Cap
$52.99 billion
Optionable
Optionable
Beta
1.08

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Shankh S. MitraMr. Shankh S. Mitra (Age 43)
    CEO & Director
    Comp: $3.81M
  • Mr. John F. Burkart (Age 60)
    Executive VP & COO
    Comp: $1.64M
  • Mr. Matthew Grant McQueen J.D. (Age 51)
    Executive VP, General Counsel & Corporate Secretary
    Comp: $1.25M
  • Mr. Nikhil Chaudhri
    Executive VP & Chief Investment Officer
  • Mr. Krishna Soma
    Senior Vice President of Corporate Finance
  • Mr. John Olympitis
    Senior VP & Head of Corporate Development
  • Ms. Pam Byrne
    Senior VP & Head of Human Capital
  • Mr. Joseph P. Weisenburger
    Senior Vice President of Relationship Management
  • Mr. Richard E. Hansen
    Vice President of Asset Management
  • Mr. Nicholas Rumanes
    Head of Development

Should I Buy Welltower Stock? WELL Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Welltower was last updated on Sunday, March 3, 2024 at 1:24 AM.

Pros

Here are some ways that investors could benefit from investing in Welltower Inc.:

  • Welltower Inc. is a REIT and S&P 500 company, providing stability and potential for growth in the real estate sector.
  • Welltower has a diversified portfolio in the healthcare infrastructure sector, including seniors housing, post-acute communities, and outpatient medical properties.
  • Recent developments show Welltower expanding its presence in key markets like the United States, Canada, and the United Kingdom, indicating strategic growth opportunities.
  • Investors can benefit from the long-term demographic trends supporting the healthcare real estate sector, such as an aging population and increased healthcare needs.
  • Welltower's stock price has shown resilience and potential for appreciation, reflecting positive investor sentiment and market performance.

Cons

Investors should be bearish about investing in Welltower Inc. for these reasons:

  • Market volatility and economic uncertainties can impact the real estate sector, affecting Welltower's performance and investor returns.
  • Regulatory changes in the healthcare industry could pose challenges for Welltower's operations and financial results.
  • Competition in the healthcare real estate market may increase, leading to pricing pressures and potential impact on Welltower's profitability.
  • Changes in healthcare policies and reimbursement rates could affect the demand for healthcare facilities, impacting Welltower's occupancy rates and revenue.
  • Investors should carefully monitor interest rate movements, as rising rates could impact the cost of capital for real estate investments like Welltower.














WELL Stock Analysis - Frequently Asked Questions

Should I buy or sell Welltower stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Welltower in the last year. There are currently 4 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WELL shares.
View WELL analyst ratings
or view top-rated stocks.

What is Welltower's stock price target for 2024?

14 equities research analysts have issued 1-year price objectives for Welltower's stock. Their WELL share price targets range from $80.00 to $115.00. On average, they predict the company's share price to reach $92.79 in the next twelve months. This suggests a possible upside of 0.1% from the stock's current price.
View analysts price targets for WELL
or view top-rated stocks among Wall Street analysts.

How have WELL shares performed in 2024?

Welltower's stock was trading at $90.17 on January 1st, 2024. Since then, WELL shares have increased by 2.8% and is now trading at $92.73.
View the best growth stocks for 2024 here
.

Are investors shorting Welltower?

Welltower saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 5,550,000 shares, a drop of 14.0% from the January 15th total of 6,450,000 shares. Based on an average daily trading volume, of 2,860,000 shares, the days-to-cover ratio is presently 1.9 days.
View Welltower's Short Interest
.

When is Welltower's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our WELL earnings forecast
.

How were Welltower's earnings last quarter?

Welltower Inc. (NYSE:WELL) posted its earnings results on Tuesday, February, 13th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by $0.79. The real estate investment trust had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.72 billion. Welltower had a trailing twelve-month return on equity of 1.47% and a net margin of 5.12%. Welltower's revenue was up 15.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.83 earnings per share.
Read the conference call transcript
.

How often does Welltower pay dividends? What is the dividend yield for Welltower?

Welltower declared a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, February 23rd will be paid a dividend of $0.61 per share on Thursday, March 7th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date of this dividend is Thursday, February 22nd.
Read our dividend analysis for WELL
.

Is Welltower a good dividend stock?

Welltower (NYSE:WELL) pays an annual dividend of $2.44 per share and currently has a dividend yield of 2.63%. The dividend payout ratio is 381.26%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, WELL will have a dividend payout ratio of 54.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WELL.

What guidance has Welltower issued on next quarter's earnings?

Welltower updated its FY 2024 earnings guidance on Tuesday, February, 13th. The company provided EPS guidance of 3.940-4.100 for the period, compared to the consensus EPS estimate of 4.000. The company issued revenue guidance of -.

What is Shankh Mitra's approval rating as Welltower's CEO?

1 employees have rated Welltower Chief Executive Officer Shankh Mitra on Glassdoor.com. Shankh Mitra has an approval rating of 100% among the company's employees. This puts Shankh Mitra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Welltower own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Welltower investors own include AT&T (T), Verizon Communications (VZ), Ventas (VTR), Johnson & Johnson (JNJ), Pfizer (PFE), Intel (INTC), Cisco Systems (CSCO), AbbVie (ABBV), Exxon Mobil (XOM) and Chevron (CVX).

Who are Welltower's major shareholders?

Welltower's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (15.53%), Cohen & Steers Inc. (7.38%), Norges Bank (4.92%), Capital International Investors (4.18%), Principal Financial Group Inc. (2.35%) and Legal & General Group Plc (1.47%).
View institutional ownership trends
.

How do I buy shares of Welltower?

Shares of WELL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:WELL) was last updated on 3/4/2024 by MarketBeat.com Staff